Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
vFinance was a diversified financial services holding company that provided investment banking, brokerage, and asset management services, primarily targeting small and micro-cap companies. While not a life sciences company itself, it was a significant financier and advisor for early-stage biotech and healthcare firms through its investment banking arm and specialized venture funds. The company operated a proprietary technology platform to match institutional investors with emerging growth companies. vFinance was publicly traded on the NASDAQ under the symbol VFIN until its acquisition in 2008.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on vFinance.